SGLT2 inhibitor alleviates hypomagnesemia in patients with chronic kidney disease: a retrospective observational study

被引:0
|
作者
Osawa, Kosuke [1 ]
Ohya, Masaki [2 ]
Yamamoto, Shuto [2 ]
Nakashima, Yuri [2 ]
Tanaka, Yusuke [2 ]
Yamano, Yukiko [2 ]
Takatsuka, Taisuke [2 ]
Araki, Shin-Ichi [2 ]
机构
[1] Wakayama Med Univ, Dept Nephrol, Wakayama, Japan
[2] Wakayama Med Univ, Sch Med, Dept Nephrol, Wakayama, Japan
关键词
D O I
10.1093/ndt/gfae069.1220
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
646
引用
收藏
页数:2
相关论文
共 50 条
  • [31] SGLT2 Inhibitors in Diabetic Kidney Disease
    Zoungas, Sophia
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (04): : 631 - 633
  • [32] SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
    Podesta, Manuel Alfredo
    Sabiu, Gianmarco
    Galassi, Andrea
    Ciceri, Paola
    Cozzolino, Mario
    BIOMEDICINES, 2023, 11 (02)
  • [33] Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
    Clifford J. Bailey
    Caroline Day
    Srikanth Bellary
    Current Diabetes Reports, 2022, 22 : 39 - 52
  • [34] Early use of SGLT2 inhibitors reduces the progression of diabetic kidney disease: a retrospective cohort study
    Pang, Shaowei
    Li, Xiaoli
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (09): : 4967 - 4978
  • [35] SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice
    Skrabic, Roko
    Kumric, Marko
    Vrdoljak, Josip
    Rusic, Doris
    Skrabic, Ivna
    Vilovic, Marino
    Martinovic, Dinko
    Duplancic, Vid
    Kurir, Tina Ticinovic
    Bozic, Josko
    BIOMEDICINES, 2022, 10 (10)
  • [36] Modeling the renoprotective mechanisms of SGLT2 inhibition in hypertensive chronic kidney disease
    Clemmer, John S.
    Yen, Timothy E.
    Obi, Yoshitsugu
    PHYSIOLOGICAL REPORTS, 2023, 11 (21):
  • [37] Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
    Bailey, Clifford J.
    Day, Caroline
    Bellary, Srikanth
    CURRENT DIABETES REPORTS, 2022, 22 (01) : 39 - 52
  • [39] Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
    Christian W. Mende
    Advances in Therapy, 2022, 39 : 148 - 164
  • [40] Modeling the renoprotective effects of SGLT2 inhibition in nondiabetic chronic kidney disease
    Clemmer, John
    Pruett, W. Andrew
    Hester, Robert
    PHYSIOLOGY, 2023, 38